(Q43433837)

23 November 2017

title

Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (English)

1 reference

methicillin-resistant Staphylococcus aureus

23 November 2017

main subject

0 references

vancomycin

1 reference

based on heuristic

inferred from title

Staphylococcus aureus

1 reference

1

1 reference

23 November 2017

4

1 reference

23 November 2017

James Hurley

12

0 references

author name string

Peter B Ward

2

1 reference

23 November 2017

Patrick G P Charles

3

1 reference

23 November 2017

Andrew Fuller

5

1 reference

23 November 2017

Philipp du Cros

6

1 reference

23 November 2017

Elizabeth A Grabsch

7

1 reference

23 November 2017

Sally A Roberts

8

1 reference

23 November 2017

Jenny Robson

9

1 reference

23 November 2017

Kerry Read

10

1 reference

23 November 2017

Narin Bak

11

1 reference

23 November 2017

Paul D R Johnson

13

1 reference

23 November 2017

Arthur J Morris

14

1 reference

23 November 2017

Barrie C Mayall

15

1 reference

23 November 2017

M Lindsay Grayson

16

1 reference

23 November 2017

language of work or name

English

0 references

publication date

29 January 2004

1 reference

Clinical Infectious Diseases

23 November 2017

published in

1 reference

23 November 2017

volume

38

1 reference

23 November 2017

issue

4

1 reference

23 November 2017

page(s)

521-528

1 reference

The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model

23 November 2017

cites work

1 reference

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know

21 January 2018

1 reference

Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin.

21 January 2018

1 reference

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

21 January 2018

1 reference

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

21 January 2018

1 reference

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital

21 January 2018

1 reference

Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis

21 January 2018

1 reference

Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing th

21 January 2018

1 reference

Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus

21 January 2018

1 reference

Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization

21 January 2018

1 reference

Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia

21 January 2018

1 reference

Vancomycin resistance in staphylococci

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/381202

1 reference

23 November 2017

1 reference